Medicofarma Biotech Spolka Akcyjna Logo

Medicofarma Biotech Spolka Akcyjna

R&D company developing innovative medicines, medical devices, and biotech products.

MDB | WAR

Overview

Corporate Details

ISIN(s):
PLINBOK00010
LEI:
259400W39H7UHW9EJP66
Country:
Poland
Address:
Warszawa Sokołowska 9/U19, 01-142 Warszawa

Description

Medicofarma Biotech Spolka Akcyjna is a research and development company specializing in innovative medicines, medical devices, and biotechnology products. The company's core mission is to design, refine, and introduce novel pharmacological solutions that address critical unmet medical needs, with a particular focus on the prevention and treatment of civilization diseases. Through its dedicated R&D Center, the company collaborates with scientific institutions and manufacturing partners, providing support in areas such as pre-formulation for generic and cosmetic products. Key research areas include the development of therapies for oncology and oral diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-18 18:43
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
Polish 1.3 KB
2024-03-06 19:35
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 3.3 KB
2024-01-03 22:51
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
Polish 1.7 KB
2024-01-02 17:16
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
Polish 4.5 KB
2023-12-31 19:41
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 2.1 KB
2023-12-31 19:33
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
Polish 2.9 KB
2023-12-31 19:24
Strategia na lata 2024-2026
Polish 2.6 MB
2023-12-31 19:24
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
Polish 1.8 KB
2023-10-26 22:42
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
Polish 2.5 KB
2023-10-23 20:42
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
Polish 6.3 KB
2023-10-11 21:07
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
Polish 1.9 KB
2023-07-20 19:38
Najwyższa ocena merytoryczna wniosku dotacyjnego NUTRITECH - Content (PL)
Polish 1.2 KB
2023-07-19 18:01
Informacja o uzyskaniu certyfikatu GMP - Content (PL)
Polish 716 bytes
2023-06-30 22:59
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 766 bytes
2023-06-02 15:22
Medicofarma_Biotech_SA_Sprawozdanie_Rady_Nadzorczej_2022_20230602_sent.pdf
Polish 345.3 KB

Automate Your Workflow. Get a real-time feed of all Medicofarma Biotech Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medicofarma Biotech Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medicofarma Biotech Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

OncoTherapy Science, Inc. Logo
Biopharmaceutical company researching and developing novel anti-cancer therapies.
Japan
4564
Optipharm.CO.,LTD Logo
Develops animal health solutions, biotherapeutics, and xenotransplantation technology.
South Korea
153710
ORAGENICS INC Logo
Biotechnology company developing intranasal therapeutics for neurological disorders.
United States of America
OGEN
Develops organoid-based technologies for drug development and regenerative medicine.
South Korea
476040
Orum Therapeutics, Inc. Logo
Clinical-stage biotech developing degrader-antibody conjugates to treat cancer.
South Korea
475830
OSR Holdings, Inc. Logo
A healthcare holding company acquiring and developing innovative therapies and solutions.
United States of America
OSRH
OS Therapies Inc Logo
Clinical-stage immunotherapy company developing treatments for HER2-positive cancers.
United States of America
OSTX
OXFORD BIODYNAMICS PLC Logo
Develops and commercializes precision medicine tests for oncology using 3D genomics.
United Kingdom
OBD
Oxurion NV Logo
Acquires majority stakes in European pharmaceutical subcontractors.
Belgium
OXUR
Pasithea Therapeutics Corp. Logo
Develops treatments for central nervous system disorders, RASopathies, and solid tumors.
United States of America
KTTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.